Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease.
Karagiannidis E, Moysidis DV, Papazoglou AS, Panteris E, Deda O, Stalikas N, Sofidis G, Kartas A, Bekiaridou A, Giannakoulas G, Gika H, Theodoridis G, Sianos G.
Karagiannidis E, et al. Among authors: deda o.
Cardiovasc Diabetol. 2022 May 7;21(1):70. doi: 10.1186/s12933-022-01494-9.
Cardiovasc Diabetol. 2022.
PMID: 35525960
Free PMC article.
Clinical Trial.